The STEP UP trial evaluated a higher investigational dose of 7.2 mg and produced even more impressive outcomes: a mean weight loss of 21%, with over 90% of participants achieving at least 5% weight reduction and one-third losing 25% or more of their body weight
Lokrantz CM, Eriksson B, Rosen I, Asztely F: Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinam
While additional research is needed to determine how GLP-1 RAs put a person at an increased risk for NAION, it may be linked to fluctuations in blood pressure and blood sugar, diabetes-related vascular issues, and low blood sugar (hypoglycemia) caused by Mounjaro
Diabetes, Obesity & Metabolism, 19 (4), 524536
Jasmine P
Who May Find This Formula Relevant If you're someone who prefers a gut-first approach to appetite management - a formula positioned around supporting your body's own signaling rather than relying on stimulants or synthetic compounds - this type of product may align with your wellness approach